In October 2026, the German National Academy of Sciences Leopoldina published a statement on post-infectious diseases, summarising the current state of healthcare provision, data infrastructure, research on pathogenesis and treatments, as well as prevention. For each of these areas, the Academy provides recommendations for short- and long-term implementation.
In their statement “Post-infectious Diseases - Healthcare, Data Infrastructure, Research, and Prevention“ (external link), the Leopoldina expert group describes the current status quo and concludes that progress on several levels is required for a better understanding of post-infectious diseases. In summary, the Academy’s statements focus on four core areas. The full statement can be accessed via the following link:
In summary, the Academy’s statements focus on four key areas:
Healthcare
The state of healthcare provision in Germany remains inadequate. Despite the existence of clinical guidelines, a stepped approach to healthcare provision has yet to be implemented comprehensively. There is also a shortage of medical professionals with the necessary expertise. Furthermore, collaboration across different levels of healthcare and medical disciplines is not yet functioning to the extent needed. What is more, there is a lack of specialised outpatient clinics. The situation is particularly critical for severely affected and housebound patients.
In patient care, the focus should therefore be on translating scientific progress into clinical practice. This includes the standardisation of diagnostics and the use of "living guidelines" (dynamic clinical guidelines that are regularly updated). This could be enabled by supporting targeted training and assistance programmes.
Data infrastructure
In Germany, research data infrastructures relevant to the study of post-infectious diseases already exist, for example, in the form of the Network of University Medicine (NUM). However, required data are currently not available to a sufficient extent, or their use in practice remains limited. Yet, a robust database is fundamental for gaining scientific insights into these conditions.
Hence, there are two key areas for action regarding data. First, the systematic provision of data must be facilitated, for example, by utilising electronic patient records and via establishing new national registries. Second, legal restrictions that hinder the linkage of data should be removed, enabling better utilisation of existing data across various institutions.
Research
The disease mechanisms identified to date in post-infectious diseases include dysregulation of the immune response, metabolism, and blood circulation, as well as viral persistence and reactivations. These underlying mechanisms can trigger chronic inflammation, autoimmunity, and mitochondrial or endothelial dysfunction. Based on current scientific evidence, it is assumed that the development of post-infectious diseases is influenced by various factors that are not yet sufficiently understood.
It appears that focusing solely on the use of drugs already approved for other conditions (so-called drug repurposing), is insufficient for addressing these disease mechanisms. Instead, clinical research aimed at developing treatments should be complemented by basic research. This should be done by applying state-of-the-art methods and techniques to uncover the underlying disease mechanisms and, in turn, identify targeted treatment options. The development of appropriate treatments should, for instance, focus on anti-inflammatory, immunomodulatory, or antiviral approaches.
Prevention
According to the Leopoldina, prevention in the context of post-infectious diseases is of central importance, given the ongoing emergence of new COVID-19 cases. The Academy argues that the "National Decade against Post-infectious Diseases" should therefore also be understood as a "National Decade for the Prevention of Post-infectious Diseases."
Preventing Long COVID and other long-term, infection-associated health consequences requires innovative approaches to vaccine development. This necessitates a greater focus on epidemiological studies to develop effective vaccines against pathogens linked to the onset of post-infectious diseases (such as the Epstein-Barr virus).
What are the conclusions of the National Academy of Sciences?
The statement addresses a range of specific challenges and provides detailed recommendations across the four key areas. In doing so, the Leopoldina summarises the current state of scientific knowledge, with the aim of raising public awareness and contributing to long-term improvements in the situation of those affected.
In their conclusion, the Academy states that implementing their recommendations would not only bring about improvement for people living with post-infectious diseases, but also for society as a whole. The statement refers, among other things, to the modelling done by the ME/CFS Research Foundation and Risklayer of the societal cost of Long COVID and ME/CFS in Germany . According to the model, the societal cost in 2025 was around 64.4 billion Euros.
The Leopoldina assumes that the long-term costs of these diseases — and thus the costs of inaction — will far exceed the costs associated with implementing their recommendations. Furthermore, from an ethical perspective, the suffering of those affected alone creates an immediate imperative to act.
Therefore, the concrete approach taken under the “National Decade Against Post-Infectious Diseases“, with its goals and funding measures, should, according to the Leopoldina, contribute to improving the long-term situation of patients.
The group of experts that developed the recommendations (external link) consists of representatives from various medical and scientific disciplines. During the preparation of the statement, several stakeholder groups were also consulted, including the patient organisation Long COVID Germany (LCD).
How can you support the work of the ME/CFS Research Foundation?
While progress has been made, there is still a long way to go before diagnosis, care and treatment of ME/CFS patients will one day become an established medical and social standard. We at the ME/CFS Research Foundation are focussing on biomedical research, which we see as a key element in solving these problems (more on this in our research funding strategy and in the recent half year report, which summarises our activities). To achieve this, we rely on broad support from private donors – those affected, relatives, families, friends, associations, schools, networks, companies, initiatives, event organisers and all supporters. If you are not able to provide direct support, you can share our stories and motivate others to help. Because only together can we achieve. this goal.
We fully translate donations and other support into scientifically excellent research, networking and ultimately visible successes, i.e. improved ME/CFS diagnostics and therapies. We are happy to work together with other organisations and initiatives - please contact us!
We appreciate all kinds of support:
Please subscribe to our newsletter:
Thank you for your support!


